Hyliion Holdings Corp. (HYLN) — Fundamental Analysis
Snapshot & Big Picture
Hyliion Holdings Corp. is a commercial trucking electrification company focused on developing hybrid and electric powertrain solutions for Class 8 semi-trucks. The company went public via SPAC in 2020 and has spent most of its post-IPO life in heavy development and early commercialization mode. Revenue was effectively zero through 2020 and has grown from a very small base since 2021, but the business remains deeply unprofitable as it works toward scale. The most recent filings (a 10-Q for the quarter ended March 31, 2026, and a 10-K for fiscal year ended December 31, 2025) reflect a company that is still burning cash while showing modest revenue growth and some improvement in operating efficiency.
Latest Quarter Snapshot (Q1 2026 — Most Current Data)
The quarter ended March 31, 2026, is the most recent reporting period available and reflects conditions more current than the annual figures below.
| Metric | Q1 2026 (Period Ended Mar 31, 2026) |
|---|---|
| Revenue | $2,832,000 |
| EBITDA | -$11,118,000 |
| Gross Margin | 7.4% |
| Operating Margin | -467.1% |
| Net Margin | -414.4% |
| Current Ratio | 10.09x |
| Debt-to-Equity | 0.00 |
| Capital Expenditures | $1,874,000 |
| CapEx-to-Revenue | 66.2% |
Q1 2026 revenue of $2.83 million is notable — it already represents 81% of full-year 2025 revenue ($3.475 million), which is an encouraging sign of acceleration if sustained. Gross margin turned slightly positive at 7.4%, and the EBITDA loss of $11.1 million is meaningfully smaller than any recent full-year quarter average. The operating and net margins remain deeply negative due to the company's overhead relative to its still-tiny revenue base, but the trajectory within the quarter is the most constructive data point in the dataset.
Profitability — Multi-Year Trend
Hyliion's profitability picture has been universally negative since inception, though the magnitude of losses has shifted materially over the years.
| Fiscal Year | Revenue | EBITDA | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| 2019 | $0 | -$10,971,000 | N/A | N/A | N/A |
| 2020 | $0 | -$21,333,000 | N/A | N/A | N/A |
| 2021 | $200,000 | -$95,213,000 | -1,268.5% | -48,048.5% | -48,024.0% |
| 2022 | $2,106,000 | -$157,803,000 | -316.8% | -7,551.3% | -7,281.9% |
| 2023 | $672,000 | -$133,858,000 | -155.4% | -20,441.8% | -18,379.5% |
| 2024 | $1,509,000 | -$61,152,000 | 6.2% | -4,261.0% | -3,449.2% |
| 2025 | $3,475,000 | -$59,597,000 | 4.9% | -1,886.4% | -1,645.7% |
The trend shows meaningful improvement: EBITDA losses peaked at -$157.8 million in 2022 and have been cut to -$59.6 million in 2025. Gross margin has finally turned positive (6.2% in 2024, 4.9% in 2025), a significant milestone indicating that the company can at least cover direct production costs on its delivered products. Operating and net margins remain severely negative, but this is largely a function of operating expenses dwarfing a still-tiny revenue base. The critical question for Hyliion is whether it can scale revenue fast enough to achieve operating leverage. The 2023 revenue dip (from $2.1M to $672K) was a notable setback, likely reflecting product/platform transitions, before recovery in 2024 and 2025.
Financial Health
Hyliion's balance sheet has been a relative bright spot throughout its history, largely a result of its SPAC transaction and subsequent equity-heavy capital structure.
| Fiscal Year | Current Ratio | Debt-to-Equity | Capital Expenditures | CapEx-to-Revenue |
|---|---|---|---|---|
| 2019 | 0.55x | -0.372 (pre-SPAC) | $349,000 | N/A (zero revenue) |
| 2020 | 69.89x | ~0.00 | $311,000 | N/A (zero revenue) |
| 2021 | 25.37x | Not reported | $2,380,000 | 1,190.0% |
| 2022 | 22.08x | Not reported | $2,885,000 | 137.0% |
| 2023 | 12.02x | Not reported | $7,401,000 | 1,101.3% |
| 2024 | 9.17x | Not reported | $16,525,000 | 1,095.1% |
| 2025 | 10.00x | Not reported | $23,740,000 | 683.2% |
| Q1 2026 | 10.09x | 0.00 | $1,874,000 | 66.2% |
Liquidity: The current ratio has declined from an extreme 69.9x in 2020 (immediately post-SPAC flush) to roughly 10x in recent periods, which is still very strong and indicates no near-term liquidity crisis. The company carries essentially no debt — debt-to-equity was not separately reported in the 2021–2025 10-K filings, and the Q1 2026 10-Q shows it at 0.00, confirming a debt-free balance sheet.
Capital Expenditures: CapEx has risen sharply and is a critical story here. It climbed from $311K in 2020 to $23.74 million in 2025, representing a significant ramp in reinvestment. As a ratio of revenue, CapEx was astronomically high in early years (when revenue was near zero), but has been declining as revenue grows — from 1,095% of revenue in 2024 to 683% in 2025, and a much more favorable 66.2% in Q1 2026. The absolute dollar increase in CapEx signals Hyliion is still building out infrastructure and production capacity, which is consistent with its early-commercialization stage. The sharp drop in the CapEx-to-revenue ratio in Q1 2026 is encouraging and may indicate that the heavy capital investment cycle is beginning to moderate relative to growing sales — but investors should watch whether this ratio continues to decline as revenue scales.
Growth
| CAGR Window | Start Year | End Year | Start Revenue | End Revenue | CAGR |
|---|---|---|---|---|---|
| 3-Year | FY 2022 | FY 2025 | $2,106,000 | $3,475,000 | 18.2% |
| 5-Year | N/A | N/A | — | — | Not available — revenue was $0 in FY 2020, making a meaningful CAGR calculation impossible |
| 10-Year | N/A | N/A | — | — | Not available — the company does not have sufficient SEC filing history extending back 10 years |
The 3-year revenue CAGR of 18.2% (FY 2022 to FY 2025) sounds respectable in isolation, but it masks significant volatility — revenue actually fell in 2023 before recovering. The 5- and 10-year windows are not calculable: the 5-year window would anchor to FY 2020, when revenue was zero, and the company simply doesn't have a 10-year SEC filing track record. The more meaningful signal may be the recent quarterly trend: Q1 2026 revenue of $2.83 million already approaching full-year 2025 levels suggests a possible acceleration, but a single quarter is insufficient to confirm a durable new growth trajectory.
Plain English Summary
Hyliion is a pre-profitability electric and hybrid powertrain company for heavy trucks that is still very much in "build and prove it" mode. The good news: the balance sheet is solid (no debt, plenty of liquidity), gross margins have turned positive for the first time, EBITDA losses are shrinking, and Q1 2026 revenue momentum looks stronger than recent full-year figures. The bad news: the company is spending far more than it earns — $23.7 million in capital expenditures in 2025 against $3.5 million in revenue — and operating losses remain enormous relative to its revenue base. The path to viability depends entirely on whether Hyliion can grow revenue fast enough and consistently enough to absorb its fixed cost structure. The 3-year revenue CAGR of 18.2% is a start, but from such a tiny revenue base, the company needs several more years of sustained, uninterrupted growth to meaningfully close the gap between spending and earnings. Investors should watch quarterly revenue trends, gross margin stability, and whether the CapEx-to-revenue ratio continues its recent improvement as the primary indicators of progress.
Leave a Comment